Kolexia
Khalifa Emmanuel Biologie médicale
Khalifa Emmanuel
Biologie médicale
Institut Bergonié
Bordeaux, France
45 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sarcomes Paragangliome Carcinome pulmonaire à petites cellules Tumeurs du poumon Carcinome pulmonaire non à petites cellules Prédisposition génétique à une maladie Tumeurs des tissus mous Tumeurs de l'utérus Phéochromocytome

Collaborateurs

Voir plus
Soubeyran Isabelle
Soubeyran Isabelle
Institut Bergonié, Bordeaux, France
Italiano Antoine
Italiano Antoine
Institut Bergonié, Bordeaux, France
Cousin Sophie
Cousin Sophie
Institut Bergonié, Bordeaux, France
Toulmonde Maud
Toulmonde Maud
Institut Bergonié, Bordeaux, France

Industries

Voir plus
AstraZeneca
7 collaboration(s)
Dernière en 2023
Pfizer
1 collaboration(s)
Dernière en 2020
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
MULTISARC: Molecular Profiling of Advanced Soft-tissue Sarcomas. A Phase III Study
Essai Clinique (Institut National de la Santé Et de la Recherche Médicale, France)   05 mars 2024
Pan-TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfalls.
Histopathology   21 novembre 2023
1634P Extensive molecular profiling of KRAS wild-type versus KRAS mutant pancreatic ductal adenocarcinoma on 233 patients
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Clinical utility of circulating tumor DNA sequencing with a large panel in patients with advanced soft-tissue sarcomas.
Cancer communications (London, England)   05 juillet 2023
Liquid versus tissue biopsy for detecting actionable alterations according to the ESMO Scale for Clinical Actionability of molecular Targets in patients with advanced cancer: a study from the French National Center for Precision Medicine (PRISM).
Annals of oncology : official journal of the European Society for Medical Oncology   17 septembre 2022
1719P Predictive value of DNA repair gene alterations for the response to platinum-based chemotherapy and immunotherapy in advanced solid tumors patients: Results from a single center molecular screening program
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
1084P Predicting KRAS G12C subtype from non-small cell lung cancer H&E slides using deep learning
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
Idylla assay on extracted DNA: advantages, limits and place in molecular screening according to the latest guidelines for non-small-cell lung cancer (NSCLC) patients.
Journal of clinical pathology   12 juillet 2022
Clinical utility of circulating tumor DNA sequencing with a large panel in patients with advanced soft-tissue sarcomas.
2022 ASCO Annual Meeting I   02 juin 2022
Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial.
BMC cancer   05 novembre 2021